Paper458200
Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity.
Takafuji ET and 3 others. J Infect Dis, 1979. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity. Papers, record 458200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/458200
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenoviruses, Human | Major topic |
| Lung Diseases | Major topic |
| Viral Vaccines | Major topic |
| Acute Disease | |
| Antibodies, Viral | |
| Hospitalization | |
| Humans | |
| Male |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38140619 | Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines. | Viruses | 2023 | https://conductscience.org/library/papers/38140619 | PubMed |
| 30960873 | Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting. | Polymers (Basel) | 2018 | https://conductscience.org/library/papers/30960873 | PubMed |
| 27105067 | Adenoviral vector-based strategies against infectious disease and cancer. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/27105067 | PubMed |
| 26085551 | Respiratory Infections in the U.S. Military: Recent Experience and Control. | Clin Microbiol Rev | 2015 | https://conductscience.org/library/papers/26085551 | PubMed |
| 23707160 | Prospects for oral replicating adenovirus-vectored vaccines. | Vaccine | 2013 | https://conductscience.org/library/papers/23707160 | PubMed |
| 19079162 | Distal IgA immunity can be sustained by alphaEbeta7+ B cells in L-selectin-/- mice following oral immunization. | Mucosal Immunol | 2008 | https://conductscience.org/library/papers/19079162 | PubMed |
| 17918073 | Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006. | Clin Infect Dis | 2007 | https://conductscience.org/library/papers/17918073 | PubMed |
| 16707047 | Co-infections of adenovirus species in previously vaccinated patients. | Emerg Infect Dis | 2006 | https://conductscience.org/library/papers/16707047 | PubMed |
| 16480793 | Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. | Vaccine | 2006 | https://conductscience.org/library/papers/16480793 | PubMed |
| 16000418 | Genomic and bioinformatics analyses of HAdV-4vac and HAdV-7vac, two human adenovirus (HAdV) strains that constituted original prophylaxis against HAdV-related acute respiratory disease, a reemerging epidemic disease. | J Clin Microbiol | 2005 | https://conductscience.org/library/papers/16000418 | PubMed |
| 12885879 | Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120. | J Virol | 2003 | https://conductscience.org/library/papers/12885879 | PubMed |
| 12522438 | Selectively replicating viral vectors. | Cancer Gene Ther | 2002 | https://conductscience.org/library/papers/12522438 | PubMed |
| 10759404 | Oncolytic viruses. | Invest New Drugs | 1999 | https://conductscience.org/library/papers/10759404 | PubMed |
| 10505113 | Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation. | Gene Ther | 1999 | https://conductscience.org/library/papers/10505113 | PubMed |
| 10490767 | Immune responses to adenovirus and adeno-associated virus in humans. | Gene Ther | 1999 | https://conductscience.org/library/papers/10490767 | PubMed |
| 10400771 | Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. | J Virol | 1999 | https://conductscience.org/library/papers/10400771 | PubMed |
| 9457426 | Use of licensed vaccines for active immunization of the immunocompromised host. | Clin Microbiol Rev | 1998 | https://conductscience.org/library/papers/9457426 | PubMed |
| 8764016 | Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach. | J Virol | 1996 | https://conductscience.org/library/papers/8764016 | PubMed |
| 8648712 | Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus. | J Virol | 1996 | https://conductscience.org/library/papers/8648712 | PubMed |
| 6870545 | Viral vaccines: the use of currently available products and future developments. | Arch Virol | 1983 | https://conductscience.org/library/papers/6870545 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/458200
GET https://conductscience.org/api/papers/v1/458200/cited_by?page=2